Company intelligence / Profile preview
FluoGuide
Copenhagen, Denmarkfluoguide.com ↗
- Ownership
- Public · FLUO
- Employees
- ~8
- Development stage
- Other
01
Overview
FluoGuide’s lead product, FG001, has demonstrated clinical benefit in aggressive brain cancers by enabling surgeons to remove additional tumor tissue in all patients studied. It has also shown efficacy in lung and head & neck cancers. The company’s approach reduces local recurrence risk, surgical complications, and healthcare costs. FG001 also functions as a photosensitizer with potential applications in photothermal and photodynamic therapy. Strategic partnerships include collaborations with Intuitive Surgical for robotic-assisted surgery.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeDevice
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Intuitive Surgical (robotic-assisted surgery)laser system manufacturerRigshospitaletUniversity of Copenhagen
Beyond the preview
Go deeper on FluoGuide.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FluoGuide.